Press Resease

Rapid Influenza Diagnostic Tests (RIDT) Market by Patient (Adult and Pediatric); by Product (Influenza B RIDT and Influenza A RIDT); by End User (Research Laboratories, Diagnostics Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Published Date: 07-Nov-2019 Category: Pharmaceutical Report Format : PDF Pages: 126 Report Code: ZMR-5012 Status : Published

Global demand for rapid influenza diagnostic tests (RIDT) market was valued at approximately USD 448.4 million in 2018, and is expected to generate revenue of around USD 684.5 million by end of 2025, growing at a CAGR of around 6.4% between 2019 and 2025.

Description

The report covers forecast and analysis for the rapid influenza diagnostic tests (RIDT) market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the rapid influenza diagnostic tests market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the rapid influenza diagnostic tests market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the rapid influenza diagnostic tests market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the rapid influenza diagnostic tests market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the rapid influenza diagnostic tests market on global and regional basis.

The study provides a crucial view on the rapid influenza diagnostic tests by segmenting the market based on product, patient, end user and region. All the segments of rapid influenza diagnostic tests market have been analyzed based on present and future trends and the market is estimated from 2018 to 2025.

Influenza is one of the major disease burdens worldwide and early detection is important for emerging pandemic strains. Influenza virus can be detected using virus isolation in cell culture, direct antigen detection or RT-PCR (reverse transcriptase-polymerase chain reaction) based detection of influenza specific RNA. Wide range of rapid detection test kits are available commercially. Rapid influenza diagnostic test (RIDT) detects presence of influenza viral nucleoprotein antigen for diagnosis of current influenza infection. Commercially used RIDTs can detect the infection within 30 minutes. These tests mostly use immunoassays to detect viral antigen. However some tests detect neuraminidase activity. Rapid detection tests help reduce blood tests and chest radiography in clinical settings.

The demand for rapid influenza diagnostic tests market is driven by growing demand for quick and cheaper diagnostic tests, increasing government initiatives to control influenza outbreaks, increasing geriatric population and technological advancements in immunoassay techniques and manufacturing of diagnostic kits. Additionally, increasing awareness, easy availability of test kits and increasing healthcare expenditure in developing countries are expected to propel the market growth. However, lack of skilled professionals may restrain the market growth.

Based on product, global rapid influenza diagnostic tests market is bifurcated into influenza B RIDT and influenza A RIDT. Influenza A RIDT accounted for largest market share in 2018 and is projected to hold its dominance over the forecast period. Growing number of population suffering from influenza worldwide will positively impact the RIDT for influenza A product market growth.

Based on patient market is segmented into adult and pediatric. Adult patient population segment accounted for the largest market share in 2018 and pediatric patient type segment is projected to grow rapidly over the forecast period. Increasing risk of influenza in pediatric patients will boost the market growth for pediatric segment.

The end user segment is divided into research laboratories, diagnostics centers, hospitals and other end users. Hospitals were the largest end users for rapid influenza diagnostic tests market in 2018. Large patient pool, presence of developed infrastructure in hospitals attribute to the largest market share.

North America held largest market share of the global rapid influenza diagnostic tests market in 2018. Government initiatives to control influenza outbreaks, growing awareness, increasing healthcare spending and availability of technological advanced products are factors driving the market in this region. Europe was second dominating market. Asia Pacific region is estimated to be highly growing market for rapid influenza diagnostic tests. Growing awareness, increasing health care spending, increasing geriatric population base are factors driving the market growth. Latin America is expected to register moderate growth over the forecast period. Middle East and Africa will register slower growth compared to other regions due to poor infrastructure and poverty.

Major players included in the report are Becton, Dickinson and Company, DiaSorin S.p.A, SA Scientific, Meridian Bioscience Inc., CorisBioconcep, Analytik Jena, Abbott, Quidel Corporation, Roche, Princeton BioMeditech Corporation among others.

The report segment of global rapid influenza diagnostic tests market as follows:

Global Rapid Influenza Diagnostic Tests Market: Product

  • Rapid Influenza Diagnostic Test for Influenza A
  • Rapid Influenza Diagnostic Test for Influenza B

Global Rapid Influenza Diagnostic Tests Market: By Patient

  • Pediatric
  • Adult

Global Rapid Influenza Diagnostic Tests Market: By End User

  • Hospitals
  • Diagnostics Centers
  • Research Laboratories
  • Other End Users

Global Rapid Influenza Diagnostic Tests Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Rapid Influenza Diagnostic Tests Market, 2016 - 2025, (USD Million)
    • 2.2. Rapid Influenza Diagnostic Tests Market: Snapshot
  • Chapter 3. Global Rapid Influenza Diagnostic Tests Market – Industry Analysis
    • 3.1. Rapid Influenza Diagnostic Tests Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Growing prevalence of influenza
      • 3.2.2. Rise in demand for rapid diagnostic tests
    • 3.3. Restraints
      • 3.3.1. Stringent regulatory guidelines
    • 3.4. Opportunity
      • 3.4.1. Growing Biopharmaceutical Industry in Emerging Market
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by product segment
      • 3.6.2. Market attractiveness analysis by patient segment
      • 3.6.3. Market attractiveness analysis by end user segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Rapid Influenza Diagnostic Tests Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global rapid influenza diagnostic tests market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Rapid Influenza Diagnostic Tests Market – Product Segment Analysis
    • 5.1. Global rapid influenza diagnostic tests market overview: by product
      • 5.1.1. Global rapid influenza diagnostic tests market revenue share, by product, 2018 and 2025
    • 5.2. Rapid Influenza Diagnostic Test for Influenza A
      • 5.2.1. Global rapid influenza diagnostic tests market by Rapid Influenza Diagnostic Test for Influenza A, 2016-2025 (USD Million)
    • 5.3. Rapid Influenza Diagnostic Test for Influenza B
      • 5.3.1. Global rapid influenza diagnostic tests market by Rapid Influenza Diagnostic Test for Influenza B, 2016-2025 (USD Million)
  • Chapter 6. Global Rapid Influenza Diagnostic Tests Market – Patient Segment Analysis
    • 6.1. Global rapid influenza diagnostic tests market overview: by patient
      • 6.1.1. Global rapid influenza diagnostic tests market revenue share, by patient, 2018 and 2025
    • 6.2. Pediatric
      • 6.2.1. Global rapid influenza diagnostic tests market by Pediatric, 2016-2025 (USD Million)
    • 6.3. Adult
      • 6.3.1. Global rapid influenza diagnostic tests market by Adult, 2016-2025 (USD Million)
  • Chapter 7. Global Rapid Influenza Diagnostic Tests Market – End User Segment Analysis
    • 7.1. Global rapid influenza diagnostic tests market overview: by end user
      • 7.1.1. Global rapid influenza diagnostic tests market revenue share, by end user, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global rapid influenza diagnostic tests market by Hospitals, 2016-2025 (USD Million)
    • 7.3. Diagnostics Centers
      • 7.3.1. Global rapid influenza diagnostic tests market by Diagnostics Centers, 2016-2025 (USD Million)
    • 7.4. Research Laboratories
      • 7.4.1. Global rapid influenza diagnostic tests market by Research Laboratories, 2016-2025 (USD Million)
    • 7.5. Other End Users
      • 7.5.1. Global rapid influenza diagnostic tests market by other end users, 2016-2025 (USD Million)
  • Chapter 8. Global Rapid Influenza Diagnostic Tests Market - Regional Analysis
    • 8.1. Global rapid influenza diagnostic tests market overview: by region
      • 8.1.1. Global rapid influenza diagnostic tests market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America rapid influenza diagnostic tests market, by country, 2016-2025 (USD Million)
      • 8.2.2. North America rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
      • 8.2.3. North America rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
      • 8.2.4. North America rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.2.5.2. The U.S. rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S. rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe rapid influenza diagnostic tests market, by country, 2016-2025 (USD Million)
      • 8.3.2. Europe rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
      • 8.3.3. Europe rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
      • 8.3.4. Europe rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.3.5.2. U.K. rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.3.5.3. U.K. rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.3.6.2. France rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.3.6.3. France rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.3.7.2. Germany rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.3.7.3. Germany rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.3.8.2. Rest of Europe rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific rapid influenza diagnostic tests market, by country, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
      • 8.4.3. Asia Pacific rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.4.5.2. China rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.4.5.3. China rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.4.6.2. Japan rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.4.6.3. Japan rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.4.7.2. India rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.4.7.3. India rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America rapid influenza diagnostic tests market, by country, 2016-2025 (USD Million)
      • 8.5.2. Latin America rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
      • 8.5.3. Latin America rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
      • 8.5.4. Latin America rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.5.5.2. Brazil rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
        • 8.5.6.2. Rest of Latin America rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa rapid influenza diagnostic tests market, 2016-2025 (USD Million)
      • 8.6.2. Middle East & Africa rapid influenza diagnostic tests market revenue, by product, 2016-2025 (USD Million)
      • 8.6.3. Middle East & Africa rapid influenza diagnostic tests market revenue, by patient, 2016-2025 (USD Million)
      • 8.6.4. Middle East & Africa rapid influenza diagnostic tests market revenue, by end user, 2016-2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. DiaSorin S.p.A
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Becton, Dickinson and Company
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. SA Scientific
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. CorisBioconcep
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Meridian Bioscience Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Abbott
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Analytik Jena
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Roche
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Quidel Corporation
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Princeton BioMeditech Corporation
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Methodology

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com